Get started
Author

Bruce Sizer

Observed names: B F SIZER, B Sizer, B. F. Sizer, B. SIZER, B. Sizer, Bruce F Sizer, Dr. Bruce Sizer
Observed institutions: Queen's University Belfast, Guy's Hospital, Nottingham University Hospitals NHS Trust, Merck KGaA, Darmstadt (Germany), Barts Health NHS Trust, Norfolk and Norwich University Hospital, Royal Sussex County Hospital, Scunthorpe General Hospital, Cancer Research UK, Hammersmith Hospital, University of Oxford, Southend Hospital, East Suffolk and North Essex NHS Foundation Trust, CRUK/MRC Oxford Institute for Radiation Oncology, Mount Vernon Cancer Centre, Kent and Canterbury Hospital, Colchester Hospital, Velindre Cancer Centre, North Middlesex Hospital, Addenbrooke's Hospital, Ipswich Hospital, Mater Adult Hospital, Essex County Hospital, Colchester Hospital University NHS Foundation Trust, University College London, Salisbury NHS Foundation Trust, Medical Research Council
OpenAlex ID: A5048633799
Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
2012 · Nicholas D. James, Syed A. Hussain, et al. · New England Journal of Medicine · 965
PDF
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
2013 · John C Araujo, Géralyn C Trudel, et al. · The Lancet Oncology · 234
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study
2020 · Simon P Bach, Alexandra Gilbert, et al. · The Lancet. Gastroenterology & hepatology · 199
PDF
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial
2014 · Harpreet Wasan, Angela M Meade, et al. · The Lancet Oncology · 126
PDF
long-term follow-up of anglian germ cell cancer group surveillance versus patients with stage 1 nonseminoma treated with adjuvant chemotherapy
2004 · R.T.D Oliver, J Ong, et al. · Urology · 99
Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long‐term survival in locally advanced rectal cancer treated by chemoradiotherapy
2016 · O. Jalil, A. Afaq, et al. · Colorectal Disease · 68
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
2024 · Chris C Parker, Noel W Clarke, et al. · The Lancet · 56
A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer
2015 · Peter Hoskin, Santhanam Sundar, et al. · JNCI Journal of the National Cancer Institute · 48
Overall survival (OS) and safety of dasatinib/docetaxel versus docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC): Results from the randomized phase III READY trial.
2013 · John C. Araujo, Geralyn C. Trudel, et al. · Journal of Clinical Oncology · 48
Results of a prospective randomised control 6 vs 12 trial: Is greater tumour downstaging observed on post treatment MRI if surgery is delayed to 12-weeks versus 6-weeks after completion of neoadjuvant chemoradiotherapy?
2016 · J. Evans, J. Bhoday, et al. · Annals of Oncology · 47
Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment
2018 · Medhat Aker, Darren Boone, et al. · Abdominal Radiology · 44
Nurse-Led Phone Call Follow-Up Clinics Are Effective for Patients With Prostate Cancer
2017 · RG Casey, L Powell, et al. · Journal of Patient Experience · 30
PDF
Locally advanced rectal cancer: histopathological correlation and predictive accuracy of serial MRI after neoadjuvant chemotherapy
2009 · D F JOHNSTON, K M LAWRENCE, et al. · British Journal of Radiology · 27
Information given to patients about adverse effects of radiotherapy: a survey of patients' views
2004 · G.C. Barnett, S.C. Charman, et al. · Clinical Oncology · 26
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations
2017 · Simon Gollins, Nick West, et al. · British Journal of Cancer · 24
PDF
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis
2021 · Shih-hsin Chen, Kenneth Miles, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 23
PDF
Intermittent chemotherapy (CT) plus continuous or intermittent cetuximab (C) in the first-line treatment of advanced colorectal cancer (aCRC): Results of the two-arm phase II randomized MRC COIN-B trial.
2012 · Harpreet Wasan, Richard A. Adams, et al. · Journal of Clinical Oncology · 17
Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer
2011 · Roger W. Motson, J. S. Khan, et al. · Surgical Endoscopy · 16
Bilateral pneumothorax as a presenting feature of metastatic angiosarcoma of the scalp
1991 · Bruce Sizer · British Journal of Radiology · 16
MRI in predicting curative resection of rectal cancer: Defining a “window of opportunity” for laparoscopic surgery
2006 · Bruce F Sizer, Tan Arulampalam, et al. · BMJ · 12
Relationship Between Baseline Rectal Tumor Length and Magnetic Resonance Tumor Regression Grade Response to Chemoradiotherapy: A Subanalysis of the TRIGGER Feasibility Study
2022 · Nicola Hodges, Nicholas Battersby, et al. · Annals of Surgical Oncology · 8
PDF
A Multicentre Randomised Trial of Ibandronate Compared to Single Dose Radiotherapy for Localised Metastatic Bone Pain in Prostate Cancer (RIB)
2011 · P. Hoskin, S. Sundar, et al. · European Journal of Cancer · 7
6006 ORAL Intermittent Chemotherapy (CT) Plus Continuous or Intermittent Cetuximab (C) in the First-line Treatment of Advanced Colorectal Cancer (aCRC): Results of the Two-arm Phase II Randomised MRC COIN-B Trial
2011 · H. Wasan, R.A. Adams, et al. · European Journal of Cancer · 6
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 5
Malignant melanoma metastasis to the urinary bladder: a rare cystoscopic finding
2013 · NA Moore, HJ Stunell, et al. · Journal of Clinical Urology · 5
Works count: 56
Citation count: 2,179
H-index: 17
I10-index: 20
Year
Topic
Type